Mycomofirel 500mg Tablet

About

Mycomofirel (mycophenolate mofetil) is a potent immunosuppressant medication primarily utilized to prevent organ rejection in patients who have undergone kidney, heart, or liver transplantation. It acts as a prodrug, rapidly converted in the body to its active form, mycophenolic acid (MPA). MPA selectively inhibits inosine monophosphate dehydrogenase (IMPDH), an enzyme critical for the de novo synthesis of guanosine nucleotides. This inhibition leads to a profound suppression of T and B lymphocyte proliferation, which are key immune cells responsible for mediating the rejection of transplanted organs. Mycomofirel is often used in combination with other immunosuppressants, such as corticosteroids and calcineurin inhibitors, to achieve optimal graft survival and minimize acute rejection episodes. Its mechanism of action specifically targets the immune cells involved in rejection, making it a cornerstone of modern transplant therapy.

Uses

• Prevention of kidney transplant rejection
• Prevention of heart transplant rejection
• Prevention of liver transplant rejection
• Treatment of certain autoimmune diseases (off-label)

Directions For Use

Take orally, usually twice daily, with or without food as directed by your physician. Do not crush, chew, or break the tablet.

Benefits

• Effectively prevents acute organ rejection episodes
• Improves long-term graft survival rates
• Allows for reduced doses of calcineurin inhibitors
• Targeted immunosuppression of lymphocytes
• Reduces risk of graft loss
• Well-established efficacy in transplant protocols

Side Effects

• Diarrhea
• Nausea and vomiting
• Abdominal pain
• Leukopenia (low white blood cell count)
• Anemia (low red blood cell count)
• Thrombocytopenia (low platelet count)
• Increased risk of infections
• Increased risk of certain cancers (e.g., lymphoma, skin cancer)
• Hypertension
• Headache
• Tremor
• Insomnia

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate gastrointestinal side effects or increase liver strain.
• Pregnancy - Mycomofirel is highly teratogenic and contraindicated in pregnancy due to severe birth defects. Effective contraception is mandatory.
• Breastfeeding - Not recommended during breastfeeding as mycophenolic acid can pass into breast milk and potentially harm the infant.
• Liver - Use with caution in patients with severe liver impairment; dose adjustments may be necessary, and liver function should be monitored.
• Kidney - Use with caution in patients with severe kidney impairment; dose adjustments may be necessary, and kidney function should be monitored.
• Lung - Monitor for new or worsening respiratory symptoms as interstitial lung disease is a known, though rare, adverse effect.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.